New β-lactam-β-lactamase inhibitor combinations in clinical development
Author:
Publisher
Wiley
Subject
History and Philosophy of Science,General Biochemistry, Genetics and Molecular Biology,General Neuroscience
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/nyas.12010/fullpdf
Reference44 articles.
1. In vivo comparison of CXA-101 (FR264205) with and without tazobactam versus piperacillin-tazobactam using human simulated exposures against phenotypically diverse gram-negative organisms;Bulik;Antimicrob. Agents Chemother.,2012
2. Epidemiological expansion, structural studies, and clinical challenges of new β-lactamases from gram-negative bacteria;Bush;Annu. Rev. Microbiol.,2011
3. Three decades of beta-lactamase inhibitors;Drawz;Clin. Microbiol. Rev.,2010
4. Kinetic interactions of tazobactam with beta-lactamases from all major structural classes;Bush;Antimicrob. Agents Chemother.,1993
5. Diazabicyclooctanes (DBOs): a potent new class of non-β-lactam β-lactamase inhibitors;Coleman;Curr. Opin. Microbiol.,2011
Cited by 118 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Approachable Synthetic Methodologies for Second-Generation β-Lactamase Inhibitors: A Review;Pharmaceuticals;2024-08-23
2. Evolving resistance landscape in gram‐negative pathogens: An update on β‐lactam and β‐lactam‐inhibitor treatment combinations for carbapenem‐resistant organisms;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2024-07
3. Synergistic Combination of Aztreonam and Ceftazidime–Avibactam—A Promising Defense Strategy against OXA-48 + NDM Klebsiella pneumoniae in Romania;Antibiotics;2024-06-12
4. In vitro pharmacokinetics/pharmacodynamics of FL058 (a novel beta-lactamase inhibitor) combined with meropenem against carbapenemase-producing Enterobacterales;Frontiers in Pharmacology;2024-04-11
5. Synthesis, Structural Investigations, DNA/BSA Interactions, Molecular Docking Studies, and Anticancer Activity of a New 1,4-Disubstituted 1,2,3-Triazole Derivative;ACS Omega;2023-08-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3